ImmunityBio, Inc. (IBRX)

ImmunityBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	265.45	104.64	181.1	34.92	15.51
Short-Term Investments	1.01	2.54	136.02	61.15	36.14
Cash & Cash Equivalents	266.46	107.18	317.12	96.06	51.65
Cash Growth	148.60%	-66.20%	230.12%	85.98%	-31.01%
Receivables	2.02	1.89	1.33	2	0
Other Current Assets	25.6	31.5	15.9	13.65	4.11
Total Current Assets	294.08	140.58	334.35	111.71	55.76
Property, Plant & Equipment	182.63	189.45	119.17	90.68	72.23
Long-Term Investments	7.77	7.47	13.98	17.53	10.75
Goodwill and Intangibles	17.09	20	1.42	1.46	0
Other Long-Term Assets	2.88	4.86	0	0	4.39
Total Long-Term Assets	210.37	221.78	134.56	109.67	87.37
Total Assets	504.45	362.36	468.91	221.38	143.12
Accounts Payable	10.33	24.49	15.36	26.35	2.24
Current Debt	5.24	434.55	302.25	5.02	3.21
Other Current Liabilities	42.71	41.83	51.39	36.77	6.12
Total Current Liabilities	58.28	500.86	369	68.13	11.56
Long-Term Debt	876.89	289.22	343.42	270.53	10.89
Other Long-Term Liabilities	155.21	22.09	0.41	1.21	0
Total Long-Term Liabilities	1,032	311.32	343.83	271.74	10.89
Total Liabilities	1,090	812.18	712.82	339.87	22.44
Total Debt	882.14	723.77	645.66	275.55	14.09
Debt Growth	21.88%	12.10%	134.32%	1855.48%	137.02%
Retained Earnings	-2,961.68	-2,378.49	-1,961.92	-1,615.13	-662.19
Comprehensive Income	0.01	0.18	0	0.12	-0.11
Shareholders' Equity	-586.99	-447.33	-242.17	-119.81	120.68
Net Cash / Debt	-615.68	-616.59	-328.55	-179.49	37.56
Net Cash / Debt Growth	-	-	-	-	-45.51%
Net Cash Per Share	-1.21	-1.54	-0.84	-0.48	0.10
Working Capital	235.8	-360.28	-34.65	43.58	44.2
Book Value Per Share	-1.15	-1.12	-0.62	-0.32	0.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).